ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for serious mental health conditions
Disease control Recruiting nowThis early-stage study is testing a new extended-release pill called LY03020 to see if it's safe and how it moves through the body. It will involve 40 Chinese adults, including both healthy volunteers and people with stable schizophrenia. Researchers will give different doses to …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for calming Alzheimer's psychosis
Symptom relief Recruiting nowThis research is testing whether an investigational drug called ACP-204 can safely reduce distressing psychotic symptoms like hallucinations and delusions in people with Alzheimer's disease. The study involves over 1,000 adults aged 55-95 who have been diagnosed with Alzheimer's …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC